<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en-GB"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Dose calibration of anti-epileptic drugs data — epileptic • landmaRk</title><!-- mathjax math --><script src="https://cdn.jsdelivr.net/npm/mathjax@3.2.2/es5/tex-mml-chtml.js" integrity="sha256-MASABpB4tYktI2Oitl4t+78w/lyA+D7b/s9GEP0JOGI=" crossorigin="anonymous"></script><script>
  window.MathJax = {
    chtml: {
      fontURL: "https://cdn.jsdelivr.net/npm/mathjax@3.2.2/es5/output/chtml/fonts/woff-v2"
    }
  };
</script><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Dose calibration of anti-epileptic drugs data — epileptic"><meta name="description" content="The SANAD (Standard and New Anti-epileptic Drugs) study (Marson
et al., 2007) is a randomized control trial of standard and new
anti-epileptic drugs, comparing effects on longer term clinical outcomes.
The data consists of longitudinal measurements of calibrated dose for the
groups randomized to a standard drug (CBZ) and a new drug (LTG). The
objective of the analysis is to investigate the effect of drug titration on
the relative effects of LTG and CBZ on treatment failure (withdrawal of the
randomized drug). There are several baseline covariates available, and also
data on the time to withdrawal from randomized drug. This version of the
data has been modified from the joineR package."><meta property="og:description" content="The SANAD (Standard and New Anti-epileptic Drugs) study (Marson
et al., 2007) is a randomized control trial of standard and new
anti-epileptic drugs, comparing effects on longer term clinical outcomes.
The data consists of longitudinal measurements of calibrated dose for the
groups randomized to a standard drug (CBZ) and a new drug (LTG). The
objective of the analysis is to investigate the effect of drug titration on
the relative effects of LTG and CBZ on treatment failure (withdrawal of the
randomized drug). There are several baseline covariates available, and also
data on the time to withdrawal from randomized drug. This version of the
data has been modified from the joineR package."><meta property="og:image" content="https://vallejosgroup.github.io/landmaRk/logo.png"></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-primary" data-bs-theme="dark" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">landmaRk</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.0.0.9000</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="nav-item"><a class="nav-link" href="../articles/landmaRk.html">Get started</a></li>
<li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/landmaRk-cv.html">Cross-validation with the landmaRk package</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/VallejosGroup/landmaRk/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>Dose calibration of anti-epileptic drugs data</h1>
      <small class="dont-index">Source: <a href="https://github.com/VallejosGroup/landmaRk/blob/main/R/data.R" class="external-link"><code>R/data.R</code></a></small>
      <div class="d-none name"><code>epileptic.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>The SANAD (Standard and New Anti-epileptic Drugs) study (Marson
et al., 2007) is a randomized control trial of standard and new
anti-epileptic drugs, comparing effects on longer term clinical outcomes.
The data consists of longitudinal measurements of calibrated dose for the
groups randomized to a standard drug (CBZ) and a new drug (LTG). The
objective of the analysis is to investigate the effect of drug titration on
the relative effects of LTG and CBZ on treatment failure (withdrawal of the
randomized drug). There are several baseline covariates available, and also
data on the time to withdrawal from randomized drug. This version of the
data has been modified from the joineR package.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu"><a href="https://rdrr.io/r/utils/data.html" class="external-link">data</a></span><span class="op">(</span><span class="va">epileptic</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="format">Format<a class="anchor" aria-label="anchor" href="#format"></a></h2>
    <p>This is a data frame in the unbalanced format, that is, with one row
per observation. The data consists of columns for patient identifier, time
of measurement, calibrated dose, baseline covariates, and survival data.
The column names are identified as follows:</p>
<dl><dt><code>id</code></dt>
<dd><p>integer: patient identifier.</p></dd>


<dt><code>time</code></dt>
<dd><p>integer: timing of clinic visit at which dose recorded
(days).</p></dd>


<dt><code>with.time</code></dt>
<dd><p>integer: time of drug withdrawal/maximum follow up
time (days).</p></dd>


<dt><code>with.status</code></dt>
<dd><p>censoring indicator (<code>1 = </code>withdrawal of
randomized drug and <code>0 = </code>not withdrawn from randomized drug/lost to
follow up).</p></dd>


<dt><code>dose</code></dt>
<dd><p>numeric: calibrated dose.</p></dd>


<dt><code>treat</code></dt>
<dd><p>factor: randomized treatment (CBZ or LTG).</p></dd>


<dt><code>age</code></dt>
<dd><p>numeric: age of patient at randomization (years).</p></dd>


<dt><code>gender</code></dt>
<dd><p>factor: gender of patient. <code>F = </code>female, <code>M
  = </code>male.</p></dd>


<dt><code>learn.dis</code></dt>
<dd><p>factor: learning disability.</p></dd>



</dl></div>
    <div class="section level2">
    <h2 id="source">Source<a class="anchor" aria-label="anchor" href="#source"></a></h2>
    <p>SANAD Trial Group, University of Liverpool. Data modified from the
joineR package.</p>
    </div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>Marson AG, Appleton R, Baker GA, et al. A randomised controlled trial
examining longer-term outcomes of standard versus new antiepileptic drugs.
The SANAD Trial. <em>Health Tech Assess</em>. 2007; <strong>11(37)</strong>.</p>
<p>Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness
of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for
treatment of partial epilepsy: an unblinded randomised controlled trial.
<em>Lancet</em>. 2007; <strong>365</strong>: 2007-2013.</p>
<p>Williamson PR, Kolamunnage-Dona R, Philipson P, Marson AG. Joint modelling of
longitudinal and competing risks data. <em>Stats Med.</em> 2008;
<strong>27(30)</strong>: 6426-6438.</p>
    </div>
    <div class="section level2">
    <h2 id="see-also">See also<a class="anchor" aria-label="anchor" href="#see-also"></a></h2>
    <div class="dont-index"><p><a href="https://rdrr.io/pkg/joineR/man/epileptic.html" class="external-link">joineR::epileptic</a>, which this dataset was modified from.</p></div>
    </div>

  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Nathan Constantine-Cooke, Victor Velasco-Pardo, Catalina Vallejos, Charlie Lees.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.3.</p>
</div>

    </footer></div>





  </body></html>

